This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

Continue
Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
New eMC coming June 2013...

Takeda UK Ltd
Takeda House, Mercury Park, Wycombe Lane, Wooburn Green, High Wycombe, Buckinghamshire, HP10 0HH
Telephone: +44 (0)1628 537 900
Fax: +44 (0)1628 526 615
WWW: http://www.Takeda.co.uk
Medical Information Direct Line: +44 (0)1628 537 900
Medical Information e-mail: medinfo@takeda.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 14/06/2013
PIL Mepact 4 mg powder for suspension for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/06/2013 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - manufacturer
Updated on 05/04/2013 and displayed until 14/06/2013
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 05/09/2012 and displayed until 05/04/2013
Reasons for adding or updating:
  • Change to side-effects
Updated on 11/05/2010 and displayed until 05/09/2012
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 03/02/2010 and displayed until 11/05/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 03/02/2010 and displayed until 03/02/2010
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics